PHILADELPHIA (WPVI) -- The FDA is investigating an alarming finding on a promising cancer therapy invented at Penn Medicine. It's being linked to rare, secondary cancers. The agency said it received ...

Please provide your email address to receive an email when new articles are posted on . WASHINGTON — CD19 chimeric antigen receptor T-cell therapy led to remission, or ceased disease progression, over ...

The United States Food and Drug Administration issued a new warning linking increased cancer risk to CAR-T cancer therapy, a treatment pioneered at Penn. Chimeric antigen receptor (CAR) T cell ...

A new literature review explores the emerging application of CAR-T cell therapy in treating people with Systemic Lupus Erythematosus (SLE). Preliminary data suggests that CAR-T therapy may ...

Please provide your email address to receive an email when new articles are posted on . “It was a huge surprise, I have to say,” Georg Schett, MD, of Friedrich Alexander University Erlangen-Nuremberg ...

Minimal Residual Disease Status in Multiple Myeloma 1 Year After Autologous Hematopoietic Cell Transplantation and Lenalidomide Maintenance Are Associated With Long-Term Overall Survival Eleven ...

Saint Louis University (SLU) Radiation Therapy students Leah Mann and Lauren Hass won first and second place, respectively, in the poster competition at the Chicago Area Radiation Therapy (CART) ...